NIH-funded research R21 grant

Exploring how transgender women respond to seasonal COVID-19 vaccines

Official title: Understanding transgender women's immune and behavioral responses to seasonal COVID-19 vaccines to improve their uptake

Funded at New York Blood Center · NIH-11053893 · Data updated 2026-11-12

This study is looking at how seasonal COVID-19 vaccines affect the immune system and behavior of transgender women who are on hormone therapy, to better understand their unique needs and improve vaccination experiences for them.

More COVID-19 research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionNew York Blood Center
NIH-funded
Lab location1 site (New York, United States)
Project startDecember 16, 2024
Project endMarch 10, 2025
Funding year2025
Award (this year)$267,121
NIH project number1R21AI183544-01A1
Project IDNIH-11053893 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adult transgender women who are undergoing gender-affirming hormone therapy.

Less likely to help

Patients who are not transgender women or those who have not undergone hormone therapy may not benefit from this research.

What this research studies

This research investigates the immune and behavioral responses of transgender women to seasonal COVID-19 vaccines, focusing on how gender-affirming hormone therapy may influence these responses. By examining the effects of sex hormones on immunity, the study aims to understand the unique challenges and needs of transgender women regarding vaccination. Participants will be adult transgender women who have undergone hormone therapy, allowing researchers to explore the relationship between hormone levels and vaccine efficacy. The findings could help improve vaccine uptake and health outcomes in this population.

Why it matters

Potential benefit: If successful, this research could lead to better vaccination strategies and improved health outcomes for transgender women.

How similar studies have gone: While there is limited research specifically on COVID-19 vaccines and transgender women, studies on sex differences in immunity suggest that understanding these dynamics could lead to significant advancements in vaccine response.

Where this research is happening

  • New York Blood Center
    New York, United States
    Active

Researchers

  • Principal investigator: Lustigman, Sara — New York Blood Center
  • Study coordinator: Lustigman, Sara

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.